Bright Biotech
3 known investors
Find your way into Bright Biotech
Sign up to find every way you can get introduced to Bright Biotech
- Your email: who you already know at Bright Biotech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Bright Biotech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Bright Biotech produces recombinant proteins, including growth factors, by expressing them in plant chloroplasts. Its proteins are aimed at cell culture and regenerative medicine applications.
Investors · 3
Big Idea Ventureslisted by Big Idea VenturesMiami · $200K – $3.5M
How we know: Big Idea Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
FoodLabslisted by FoodLabsBerlin
How we know: FoodLabs's portfolio page · funding news · Not right? Tell us
CPT CapitalreportedLondon
How we know: funding news · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- BRIGHT BIOTECH LIMITED
- Company number
- 12253910
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 10 Oct 2019
- Registered office
- Rutherford House Unit 16 Pencroft Way, Manchester Science Park, Manchester, M15 6SZ
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 20 Sept 2025 · next due 4 Oct 2026
Current officers · 4
- Mohammad Farid Khan — secretary, appointed 10 Oct 2019
- Mohammad El Hajj — director, appointed 10 Oct 2019
- Adrian Friederich — director, appointed 30 Apr 2025
- Mohammad Farid Khan — director, appointed 3 Oct 2022
Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Bright Biotech do?
- Bright Biotech produces recombinant proteins, including growth factors, by expressing them in plant chloroplasts. Its proteins are aimed at cell culture and regenerative medicine applications.
- Who are Bright Biotech's investors?
- Bright Biotech's investors include Big Idea Ventures, FoodLabs, CPT Capital.



